Tag: Hormone Replacement Therapy
USPSTF Advises Against Hormone Therapy to Prevent Chronic Conditions
USPSTF recommends against hormone therapy for primary prevention of chronic conditions in postmenopausal persons
FDA Approves First Oral Hormone Therapy for Advanced Prostate Cancer
Phase 3 trial data show 96.7 percent of patients who received Orgovyx achieved and maintained castrate levels of testosterone
Female Hormone Rx Not Tied to Retinal Vascular Occlusion
No increase seen in risk for occlusion of retinal artery, vein among women filling prescription for female hormone therapy
Factors Tied to Hormone Therapy Use After Oophorectomy ID’d
Age, education, preventive mastectomy linked to hormone therapy use in BRCA mutation carriers
Hormone Therapies Tied to Brain Changes in Menopausal Women
Circulating levels of pituitary-ovarian hormones linked to changes in WMH in menopausal women
Reproductive Health Guidelines Issued for Rheumatic Diseases
Evidence reviewed for contraception, fertility, pregnancy, HRT, medication use in RMD patients
Longer Hormone Therapy Tied to Less Muscle Loss in Menopause
In large study of postmenopausal women, sarcopenia lower in participants with history of prolonged HT
SABCS: Breast Cancer Rates Opposite for Estrogen, Estrogen + Progestin
In postmenopausal women, breast cancer incidence down with estrogen alone, up with CEE + MPA
Age Modifies Effects of Estrogen Therapy in Women Without Ovaries
Women aged 50 to 59 years with BSO had treatment-associated decrease in all-cause mortality
Type and Timing of Menopausal HRT Affect Risk for Breast Cancer
Some excess risk persists for >10 years after ceasing therapy; magnitude varies with duration of use
